Kodiak Sciences (KOD)’ tabirafusp alfa was granted FDA orphan designation as a treatment of uveitic macular edema, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
